Making some sense out of recent headlines: Much

Much has been made of the 6000% rise in MDBX since being featured in WSJ.

Here is the trading data

11/16/12    65.54    65.54    15.00    20.00  -185.00         1,048

11/15/12   100.00   215.00   100.00   205.00  +161.10         1,470

11/14/12    28.00    43.90    27.50    43.90   +33.10         2,566

11/13/12   7.3800  29.0000   7.3800  10.8000  +4.8000           550

11/12/12   4.7500   6.0000   4.7500   6.0000  +1.7500           833

11/09/12   3.7000  10.5900   3.7000   4.2500  +0.8000           695

11/08/12   3.4500   3.4500   3.4500   3.4500  +0.0000             0

11/07/12   3.4400   3.4500   3.4400   3.4500  +0.3100           600

11/06/12   3.1400   3.1400   3.1400   3.1400  +0.0000             0

11/05/12   3.1400   3.1400   3.1400   3.1400  +0.2400           150

11/02/12   2.9000   2.9000   2.9000   2.9000  +0.0000             0

There is only 13M shares outstanding. This stock went up 6000% on volume of around 5000 shares. Even the CEO of the Company said:

Dr. Bruce Bedrick, CEO of Medbox suggested that while the company's present business strategy is working well and their new product line continues to garner interest in the conventional pharmaceutical distribution channel, the company attributes the share price increase to a lack of float and not based upon present business economics.

Notice too that the stock was down $185.00 a share today on just over 1000 shares traded. So this is not representative at all. There is 0 liquidity. It means nothing because with such thin volume, no one can get in or out except maybe one or two people.